Huang, Yi-Jie <br/><br/>
On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy.  [electronic resource] 

 -  Journal of the Chinese Medical Association : JCMA  Jun 2017 
 - 341-346 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1728-7731 
<br/><br/><label>Standard No.: </label>10.1016/j.jcma.2016.12.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>DNA, Viral--blood<br/>Female<br/>Guanine--analogs & derivatives<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Seroepidemiologic Studies<br/>Young Adult